Larotrectinib for Previously Untreated TRK Fusion Pediatric Solid Tumors and TRK Fusion Relapsed Pediatric Acute Leukemias

Grant

Date/time Interval

  • October 5, 2020 - October 4, 2025

    • Awarded By

    Total Award Amount

  • 500.00

    • Direct Costs

  • 368.00

    • Sponsor Award Id

    • Contributor

  • Gregory Friedman M.D.   Principal Investigator